Maculogix
1 known investors
Lumithera develops Valeda PBM, an FDA-authorized photobiomodulation light delivery system for treating dry age-related macular degeneration (AMD) to improve and maintain vision. The non-invasive treatment targets retinal cellular health by using specific light wavelengths to enhance mitochondrial energy production.
HealthtechMedical Devices